Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,327,169
+$140,731 QoQ
Shares Held
3,665
+8.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,508
of 3,139 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. AMGN ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
This page
|
3,665 | $1,327,169 |
All Filings in AMGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,327,169 | 3,665 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,186,438 | 3,372 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,115,472 | 3,408 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,000,399 | 3,545 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $979,468 | 3,508 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,195,105 | 3,836 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,001,639 | 3,843 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,329,116 | 4,125 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,290,730 | 4,131 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,108,563 | 3,899 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,089,003 | 3,781 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,037,413 | 3,860 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $956,462 | 4,308 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,041,942 | 4,310 | Shares | Sole | 2023-04-12 | |
| 2022-06-30 | $1,118,206 | 4,596 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,105,117 | 4,570 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,047,910 | 4,658 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,142,781 | 5,374 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,513,200 | 6,208 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,347,306 | 5,415 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,075,105 | 4,676 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||